Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionAflibercept 40mg
Eylea 40mg/ml Injection
You Searched
Eylea 40mg/ml Injection
Bayer Zydus Pharma Pvt. Ltd.
₹56,693
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Diabetic macular edema (accumulation of fluid in eye of diabetic patients)
Customers also bought
More About Eylea
Benefits
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
Eylea 40mg/ml Injection is an anti-vascular endothelial growth factor (anti-VEGF) medication. It works by reducing the formation of abnormal blood vessels that damage the retina and may cause vision loss in diabetic macular edema.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Eylea 40mg/ml Injection . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Eylea 40mg/ml Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Eylea 40mg/ml Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Eylea 40mg/ml Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Manufacturer Address
Bayer House, Central Avenue, Hiranandani Estate, Thane (west) Thane 400607 India
References
Afilbercept (04 Apr. 2019)
Aflibercept (23 Oct. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.